2012
DOI: 10.1021/ja303280r
|View full text |Cite
|
Sign up to set email alerts
|

Cholinesterase-Responsive Supramolecular Vesicle

Abstract: Enzyme-responsive, amphiphilic self-assembly represents one of the increasingly significant topics in biomaterials research and finds feasible applications to the controlled release of therapeutic agents at specific sites where the target enzyme is located. The supramolecular approach, using "superamphiphiles", provides a smart way to fabricate drug delivery systems responsive to enzymatic catalysis. In this work based on the concept of supramolecular chemistry, we report an enzyme-responsive vesicle using p-s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
255
0
4

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 391 publications
(260 citation statements)
references
References 67 publications
(24 reference statements)
1
255
0
4
Order By: Relevance
“…Afterward, they further developed an enzymeresponsive supramolecular vesicle by employing biocompatible p-sulfonatocalix [4]arene (SC4A) to deliver tacrine specifically for the treatment of Alzheimer's disease. 198 The binary vesicle was formed by the host−guest complexation between SC4A and myristoylcholine. The vesicle exhibited highly specific and efficient responsiveness to cholinesterase enzyme that could break the hydrophilic−hydrophobic balance, leading to the disassembly of the binary vesicle and thus the release of loaded drugs.…”
Section: Drug Deliverymentioning
confidence: 99%
“…Afterward, they further developed an enzymeresponsive supramolecular vesicle by employing biocompatible p-sulfonatocalix [4]arene (SC4A) to deliver tacrine specifically for the treatment of Alzheimer's disease. 198 The binary vesicle was formed by the host−guest complexation between SC4A and myristoylcholine. The vesicle exhibited highly specific and efficient responsiveness to cholinesterase enzyme that could break the hydrophilic−hydrophobic balance, leading to the disassembly of the binary vesicle and thus the release of loaded drugs.…”
Section: Drug Deliverymentioning
confidence: 99%
“…5 U mL −1 butyrylcholinesterase (BChE) was employed according to the average activity of cholinesterase present in human tissues 47, 48. Incubation with BChE for 2 d converted DC to DA,49, 50, 51, 52 and then the DC micelles changed to the DA vesicles. Irradiation at 254 nm for 5 min led to the formation of the blue‐form PDA, and followed by a warming process at 37 °C, the desired fluorescent polymerized vesicles, red‐form PDA, were expectedly constructed, exhibiting red emission over 600 nm (Figure S14, Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…Polymers that degrade by hydrolysis, such as polyanhydrides 25,26 , poly(orthoesters) 2,27 , poly(caprolactone), and poly(lactic acid) and poly(glycolic acid) 28,29 are widely used for drug delivery. However, polymers that undergo enzyme-catalyzed degradation 4 are becoming attractive as site-specific delivery vehicles due to the localized concentration of enzymes throughout the body as well as the specificity of enzymatic attack 30,31 . A relatively small number of researchers have investigated the use of hydrogels with enzyme-degradable peptide components for the purpose of drug delivery to the small intestine 30,32,33 , where enzymes such as trypsin, chymotrypsin, and cathepsin-β are prevalent 34 .…”
Section: Introductionmentioning
confidence: 99%